NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Horrific QOL?

Nope. Don't facts get in the way of fear mongering:

The addition of TTFields to standard treatment with temozolomide for patients with glioblastoma results in improved survival without a negative influence on HRQoL except for more itchy skin, an expected consequence from the transducer arrays.